Advertisement

Topics

Acceleron Reports Fourth Quarter and Year Ended 2016 Operational and Financial Results

07:00 EST 1 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
- Luspatercept Phase 3 trials to complete enrollment in both the MDS (“MEDALIST”) and beta-thalassemia (“BELIEVE”) trials in 2H 2017 - - Presented data from five abstracts on luspatercept and sotatercept at the ...

Other Sources for this Article

Acceleron Pharma Inc.
Todd James, IRC, 617-649-9393
Senior Director, Investor Relations and Corporate Communications
or
Media:
BMC Communications
Brad Miles, 646-513-3125

NEXT ARTICLE

More From BioPortfolio on "Acceleron Reports Fourth Quarter and Year Ended 2016 Operational and Financial Results"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...